摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Bpoc-Ser(But) | 47634-33-3

中文名称
——
中文别名
——
英文名称
Bpoc-Ser(But)
英文别名
Bpoc.Ser(tBu).OH;Bpoc-Ser(But)-OH;2-(p-Biphenylyl)-isopropyloxycarbonyl-O-tert.-butyl-serin;N-(((2-([1,1'-Biphenyl]-4-yl)propan-2-yl)oxy)carbonyl)-O-(tert-butyl)-L-serine;(2S)-3-[(2-methylpropan-2-yl)oxy]-2-[2-(4-phenylphenyl)propan-2-yloxycarbonylamino]propanoic acid
Bpoc-Ser(Bu<sup>t</sup>)化学式
CAS
47634-33-3
化学式
C23H29NO5
mdl
——
分子量
399.487
InChiKey
RKFLTEIFFLLOTG-IBGZPJMESA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.1
  • 重原子数:
    29
  • 可旋转键数:
    9
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.39
  • 拓扑面积:
    84.9
  • 氢给体数:
    2
  • 氢受体数:
    5

反应信息

  • 作为反应物:
    描述:
    Bpoc-Ser(But)三甲基氯硅烷苯酚 作用下, 以 二氯甲烷 为溶剂, 生成 O-叔丁基-L-丝氨酸
    参考文献:
    名称:
    Selective deprotection of the N.alpha.-tert-butyloxycarbonyl group in solid phase peptide synthesis with chlorotrimethylsilane in phenol
    摘要:
    The repetitive deprotection of the N(alpha)-tert-butyloxycarbonyl group during solid phase peptide synthesis was found to be efficient and quantitative by the use of a mild new reagent containing 1 M chlorotrimethylsilane and 1 M phenol in dichloromethane. Kinetic studies showed that the half-life for the reaction at 22-degrees-C with Boc-Val-resin was 17.5 min, a 40-fold increase over the rate in the absence of phenol. The reaction is not due to the presence of HCI in the reagent. The selectivity between the removal of the N(alpha)-tert-butyloxycarbonyl group and benzylic esters, ethers, and carbonate side chain protecting groups was >10(5) and relative to the anchoring benzyl ester bond to the resin support it was 6 X 10(3). This is a marked improvement over the selectivity of the conventional 50% trifluoroacetic acid in CH2Cl2 deprotecting agent and significantly reduces the accumulated byproducts resulting from losses of benzylic groups. The cleavage of the tert-butyl urethane was first order in Me3SiCl and second order in C6HrOH. The preferred reagent is 1 M Me3SiCl-3 M C6H5OH-CH2Cl2 and the deprotection time is 20 min (t1/2 = 1.8 min for Boc-Val-OCH2-resin). Evidence for the mechanism of the reaction was deduced. Several peptides, including Leu-enkephalin, [valine-5]-angiotensin II, and glucagon were successfully synthesized in high yields and excellent purity by the stepwise solid phase method using this new reagent.
    DOI:
    10.1021/jo00071a028
  • 作为产物:
    描述:
    2-(4-联苯基)-2-丙醇吡啶 作用下, 以 二氯甲烷 为溶剂, 生成 Bpoc-Ser(But)
    参考文献:
    名称:
    Schnabel,E. et al., Justus Liebigs Annalen der Chemie, 1971, vol. 743, p. 69 - 76
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Tritiated peptides. Part 11. Synthesis of [4-3H-Phe6]-, [4-3H-Phe11]-, and [4-3H-Phe6,11]-somatostatin and the metabolite [des-Ala1]-somatostatin
    作者:Mark C. Allen、Derek E. Brundish、John R. Martin、Roy Wade
    DOI:10.1039/p19810002040
    日期:——
    ion-exchange and high-pressure liquid chromatography, and by enzymic digestion of the products modified by reduction and aminoethylation. The synthesis of the metabolite [des-Ala1]-somatostatin is described. The syntheses of [Phe(I)6]-, [Phe(I)11]- and [Phe(I)6,11]-somatostatin are described.
    合成方法描述了生长抑素+在位置6和11的苯丙酸残基中分别用tri标记,在残基6和11处分别用by标记,分别通过完全保护的还原性化反应使比放射性活度分别为15.5、13.8和14.1 Cim mol –1。前体。半胱酸残基受S-三苯甲基保护,二键由化oxidation化的受保护前体形成。通过酸性解,离子交换和高压液相色谱,以及通过酶消化经还原和乙基化改性的产物,评估产物的纯度。描述了代谢物[des-Ala 1 ]-生长抑素的合成。[Phe(描述了I)6 ]-,[Phe(I)11 ]-和[Phe(I)6,11 ]-生长抑素
  • Peptides—XXXIX
    作者:I.J. Galpin、B.K. Handa、G.W. Kenner、S.R. Ohlsen、R. Ramage
    DOI:10.1016/0040-4020(80)80119-0
    日期:1980.1
    The synthesis of the fully protected octadecapeptide fragment (50–67) was achieved by combination of the subfragments 50–54,55–60 and 61–67. Single routes to two of these fragments are described but the fragment (55–60) was prepared by two different approaches. In this case salt-coupling techniques alleviated serious solubility problems. Fragment couplings were achieved using DCCI/HONSu.
    完整保护的十八肽片段(50-67)的合成通过亚片段50-54、55-60和61-67的组合实现。描述了到达其中两个片段的单条途径,但片段(55-60)是通过两种不同的方法制备的。在这种情况下,盐偶联技术可缓解严重的溶解性问题。使用DCCI / HONSu实现片段偶联。
  • Peptides-XXXXV
    作者:I.J. Galpin、G.W. Kenner、R. Ramage、W.D. Thorpe
    DOI:10.1016/s0040-4020(01)98919-7
    日期:1981.1
  • Thyrocalcitonin V.. Synthese und Charakterisierung des gesch�tzten Aufbaufragments ?-Thyrocalcitonin-(1-9)-nonapeptid
    作者:B. Kamber、W. Rittel
    DOI:10.1002/hlca.19690520421
    日期:——
    AbstractIn the recently [1] [4] described synthesis of the hypocalcaemic hormone α‐thyrocalcitonin (I) isolated from porcine thyroid glands, the protected nonapeptide sequence 1–9, represented an important intermediate. The present report describes in detail the synthesis of III in which the disulfide ring present in I is already formed. Fragment coupling of the sequences 1–4 and 5–9 led to the protected open chain intermediate Boc‐Cys(Trt)‐Ser(But)‐Asn‐Leu‐Ser(But)‐Thr(But)‐Cys(Trt)‐Val‐Leu‐OH which was obtained in cristalline form. After removal of the protecting S‐trityl groups by mercury acetate as described by ZERVAS, et al. [5], ring closure leading to III was effected by means of diiodoethane according to WEYGAND & ZUMACH [6]. Purification of III was achieved by counter current distribution. Removal of protecting groups by trifluoroacetic acid gave the free α‐thyrocalcitonin‐(1–9)‐nonapeptide IV, which was devoid of biological activity.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫